title: [Severe constriction of the visual field associated with vigabatrin discovered by thorough examination of a 17-year old girl].
authors.forename: A
authors.initials: A
authors.lastname: Roubergue
authors.forename: B
authors.initials: B
authors.lastname: Pelosse
authors.forename: D
authors.initials: D
authors.lastname: Doummar
authors.forename: P
authors.initials: P
authors.lastname: Beauvais
authors.forename: M
authors.initials: M
authors.lastname: Montchilova
authors.forename: B
authors.initials: B
authors.lastname: Gonthier
authors.forename: T
authors.initials: T
authors.lastname: Billette de Villemeur
mesh_terms: D000293:Adolescent; D000927:Anticonvulsants / Q000009:adverse effects*; D004828:Epilepsies, Partial / Q000188:drug therapy*; D005260:Female; D006429:Hemiplegia; D006801:Humans; D020888:Vigabatrin; D014786:Vision Disorders / Q000139:chemically induced* / Q000175:diagnosis; D014794:Visual Fields; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000927:Anticonvulsants; D005680:gamma-Aminobutyric Acid; D020888:Vigabatrin